Healthcare Industry News: Lundbeck A/S

Merck & Co., Inc. and Lundbeck Discontinue Joint Development Program for Gaboxadol, an Investigational Compound for Insomnia

Source: Merck

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!